{"id":"https://openalex.org/W7207520292","doi":"https://doi.org/10.1158/2643-3230.c.8690584","title":"Data from CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles","display_name":"Data from CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles","publication_year":2026,"publication_date":"2026-09-03","ids":{"openalex":"https://openalex.org/W7207520292","doi":"https://doi.org/10.1158/2643-3230.c.8690584"},"language":"en","primary_location":{"id":"doi:10.1158/2643-3230.c.8690584","doi":"https://doi.org/10.1158/2643-3230.c.8690584","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2643-3230.c.8690584","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2643-3230.c.8690584","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077987296","display_name":"Evey Y. F. Zheng","orcid":"https://orcid.org/0009-0002-1815-4393","observed_orcids":["https://orcid.org/0009-0002-1815-4393"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evey Y.F. Zheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-1815-4393","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090453486","display_name":"Chung-Hsi Wang","orcid":"https://orcid.org/0009-0008-9513-0233","observed_orcids":["https://orcid.org/0009-0008-9513-0233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chung-Hsi Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-9513-0233","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059108040","display_name":"Toshiki Ochi","orcid":"https://orcid.org/0000-0001-8440-6144","observed_orcids":["https://orcid.org/0000-0001-8440-6144"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshiki Ochi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8440-6144","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076868052","display_name":"Yota Ohashi","orcid":"https://orcid.org/0009-0004-5548-6519","observed_orcids":["https://orcid.org/0009-0004-5548-6519"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yota Ohashi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-5548-6519","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110443958","display_name":"Fumie Ihara","orcid":"https://orcid.org/0009-0005-5932-6544","observed_orcids":["https://orcid.org/0009-0005-5932-6544"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fumie Ihara","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-5932-6544","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087174638","display_name":"Saori Fukao","orcid":"https://orcid.org/0009-0009-4484-0689","observed_orcids":["https://orcid.org/0009-0009-4484-0689"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saori Fukao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-4484-0689","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013308350","display_name":"Yusuke Ito","orcid":"https://orcid.org/0000-0002-3239-1152","observed_orcids":["https://orcid.org/0000-0002-3239-1152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yusuke Ito","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3239-1152","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084842507","display_name":"Giselle M. Boukhaled","orcid":"https://orcid.org/0000-0002-6567-6234","observed_orcids":["https://orcid.org/0000-0002-6567-6234"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giselle M. Boukhaled","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6567-6234","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036258389","display_name":"Ben X. Wang","orcid":"https://orcid.org/0000-0003-1842-7371","observed_orcids":["https://orcid.org/0000-0003-1842-7371"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ben X. Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1842-7371","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042579094","display_name":"Dong-Hoon Han","orcid":"https://orcid.org/0009-0006-3456-1027","observed_orcids":["https://orcid.org/0009-0006-3456-1027","https://orcid.org/0009-0001-7030-3280"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dong-Hoon Han","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-3456-1027","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149858422","display_name":"Xinyu Wei","orcid":"https://orcid.org/0009-0009-0930-7272","observed_orcids":["https://orcid.org/0009-0009-0930-7272"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinyu Wei","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-0930-7272","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073407450","display_name":"Priyanka Yolmo","orcid":"https://orcid.org/0009-0001-5942-9392","observed_orcids":["https://orcid.org/0009-0001-5942-9392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priyanka Yolmo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-5942-9392","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080479973","display_name":"Brian D. Burt","orcid":"https://orcid.org/0009-0002-1846-7453","observed_orcids":["https://orcid.org/0009-0002-1846-7453"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian D. Burt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-1846-7453","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024927053","display_name":"Kayoko Saso","orcid":"https://orcid.org/0009-0008-5808-2252","observed_orcids":["https://orcid.org/0009-0008-5808-2252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kayoko Saso","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-5808-2252","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062541334","display_name":"Yukiko Matsunaga","orcid":"https://orcid.org/0000-0002-1392-5681","observed_orcids":["https://orcid.org/0000-0002-1392-5681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yukiko Matsunaga","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1392-5681","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074940171","display_name":"Dalam Ly","orcid":"https://orcid.org/0000-0002-1177-0225","observed_orcids":["https://orcid.org/0000-0002-1177-0225"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dalam Ly","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1177-0225","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090849761","display_name":"Yuki Kagoya","orcid":"https://orcid.org/0000-0002-6216-6730","observed_orcids":["https://orcid.org/0000-0002-6216-6730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuki Kagoya","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6216-6730","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008158683","display_name":"Marcus Otho Butler","orcid":"https://orcid.org/0000-0002-9840-7057","observed_orcids":["https://orcid.org/0000-0002-9840-7057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcus O. Butler","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9840-7057","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026397928","display_name":"Mark David Minden","orcid":"https://orcid.org/0000-0002-9089-8816","observed_orcids":["https://orcid.org/0000-0002-9089-8816"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark D. Minden","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9089-8816","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058104480","display_name":"Naoto Hirano","orcid":"https://orcid.org/0000-0001-9070-4754","observed_orcids":["https://orcid.org/0000-0001-9070-4754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoto Hirano","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9070-4754","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9419999718666077},{"id":"https://openalex.org/keywords/hla-class-ii","display_name":"HLA class II","score":0.6899999976158142},{"id":"https://openalex.org/keywords/cross-presentation","display_name":"cross-presentation","score":0.7260000109672546},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.4440000057220459},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.8159999847412109},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.796999990940094},{"id":"https://openalex.org/keywords/hla-restriction","display_name":"HLA restriction","score":0.5249999761581421},{"id":"https://openalex.org/keywords/peptide-specific-antibodies","display_name":"peptide-specific antibodies","score":0.38199999928474426},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.7020999789237976},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5690000057220459},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.552299976348877},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.511900007724762},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5092999935150146},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.486299991607666},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.47440001368522644},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.3928000032901764},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.3763999938964844},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3702999949455261},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3698999881744385},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35420000553131104},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3474000096321106},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3440999984741211},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32899999618530273},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3012999892234802},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.28619998693466187},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.28450000286102295},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.27070000767707825},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.26750001311302185},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.26440000534057617},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.26330000162124634}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2643-3230.c.8690584","doi":"https://doi.org/10.1158/2643-3230.c.8690584","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2643-3230.c.8690584","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2643-3230.c.8690584","doi":"https://doi.org/10.1158/2643-3230.c.8690584","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2643-3230.c.8690584","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7203444985","https://openalex.org/W4412024111","https://openalex.org/W7207593445","https://openalex.org/W7207865872","https://openalex.org/W7207682426","https://openalex.org/W7207668921","https://openalex.org/W7207781632","https://openalex.org/W2560318964","https://openalex.org/W7207674126","https://openalex.org/W2557467639"],"abstract_inverted_index":{"Abstract":[0],"Chimeric":[1],"antigen":[2],"receptor":[3],"(CAR)":[4],"technology":[5],"has":[6],"revolutionized":[7],"B-cell":[8],"malignancy":[9],"treatment":[10],"by":[11,57,83],"enabling":[12],"T":[13,25,65,96],"cells":[14,26,97,101],"to":[15,37,133,181],"effectively":[16],"recognize":[17],"and":[18,33,105,108,115,127,136,185],"target":[19],"lineage-specific":[20],"surface":[21,42,58],"antigens.":[22],"However,":[23],"CAR":[24,50,152,171,178],"show":[27],"limited":[28],"efficacy":[29],"against":[30,73,173],"myeloid":[31],"neoplasms":[32],"solid":[34],"tumors":[35],"due":[36],"challenges":[38],"in":[39,102,113,116],"identifying":[40],"suitable":[41],"targets.":[43],"In":[44],"this":[45],"study,":[46],"we":[47,149],"present":[48],"a":[49,74,103,129,134,151,168],"targeting":[51,155],"the":[52,78,143],"intracellular":[53,157,174],"WT1":[54,75,159],"oncoprotein,":[55],"cross-presented":[56],"HLA":[59,93,125],"class":[60],"II":[61],"(HLA-II)":[62],"alleles.":[63],"WT1-CAR":[64,95],"cells,":[66],"derived":[67],"from":[68],"an":[69,110,156],"antibody":[70],"raised":[71],"solely":[72],"peptide,":[76],"recognized":[77,99],"WT1330\u2013348":[79],"peptide":[80],"promiscuously":[81],"presented":[82,160],"18":[84],"out":[85],"of":[86,146],"20":[87],"tested":[88],"HLA-II":[89,163],"alleles,":[90],"overcoming":[91],"traditional":[92,124],"restrictions.":[94],"specifically":[98],"leukemic":[100],"WT1-":[104],"HLA-II\u2013dependent":[106],"manner":[107],"mediated":[109],"antitumor":[111],"response":[112],"vitro":[114],"vivo.":[117],"This":[118],"approach":[119,154],"broadens":[120],"CAR-targetable":[121],"antigens":[122],"beyond":[123],"restrictions":[126],"offers":[128],"promising":[130],"therapeutic":[131],"option":[132],"wide":[135],"genetically":[137],"diverse":[138,162],"patient":[139,186],"population.":[140],"Significance:":[141],"Leveraging":[142],"promiscuous":[144],"binding":[145],"HLA-II\u2013peptide":[147],"complexes,":[148],"developed":[150],"T-cell":[153,179],"oncoprotein":[158],"across":[161],"families.":[164],"Our":[165],"study":[166],"establishes":[167],"framework":[169],"for":[170],"therapies":[172],"antigens,":[175],"extending":[176],"potential":[177],"applications":[180],"new":[182],"cancer":[183],"types":[184],"populations.":[187]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-09-04T00:00:00"}